SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Morgan Stanley Maintains Equal-Weight on Voyager Therapeutics, Lowers Price Target to $14

Morgan Stanley maintains Voyager Therapeutics (NASDAQ:VYGR) with a Equal-Weight and lowers the price target from $15 to $14.

Benzinga · 03/04/2020 13:26

Morgan Stanley maintains Voyager Therapeutics (NASDAQ:VYGR) with a Equal-Weight and lowers the price target from $15 to $14.